Platelets release proinflammatory microparticles in anti-neutrophil cytoplasmic antibody-associated vasculitis

被引:20
|
作者
Miao, Di [1 ,2 ,3 ,4 ,5 ]
Ma, Tian-Tian [1 ,2 ,3 ]
Chen, Min [1 ,2 ,3 ]
Zhao, Ming-Hui [1 ,2 ,3 ,5 ]
机构
[1] Peking Univ, Inst Nephrol, Hosp 1, Div Renal, Beijing, Peoples R China
[2] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China
[3] Minist Educ China, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing, Peoples R China
[4] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China
[5] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
关键词
vasculitis; ANCA; platelets; microparticle; ANCA-ASSOCIATED VASCULITIS; CIRCULATING MICROPARTICLES; THROMBOEMBOLIC EVENTS; RENAL HISTOLOGY; NEUTROPHIL; GRANULOMATOSIS; INFLAMMATION; THROMBOSIS; ARTHRITIS; PROMOTES;
D O I
10.1093/rheumatology/kez044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The biological functions of the platelets contributing to ANCA-associated vasculitis (AAV) are largely unclear. The current study aimed to investigate the potential role of platelet-derived microparticles (PMPs) in AAV. Methods. In the current study, microparticles in AAV patients were analysed by flow cytometry, and PMPs were probed for relative levels of 640 bioactive proteins secreted from patients' platelets using antibody microarrays. These data were then correlated with clinical and pathological parameters. Results. PMPs were significantly increased in 69 AAV patients, predominantly MPO-ANCA positive patients in active stage compared with in remission [4406.8/mu l (2135.4, 5485.0) vs 549.7/mu l (350, 708.5), P < 0.0001], and 43% of microparticles in active AAV were PMPs. Compared with 15 patients in remission, highly expressed proinflammatory molecules in the microparticles from platelets in 15 AAV patients in active stage revealed that potential functions of PMPs were promotion of the effect of chemotaxis, adhesion, growth and apoptosis (all the patients for array analysis were MPO-ANCA positive). The level of PMPs had a significant association with disease activity, inflammation, and renal damage. Conclusion. PMPs may serve as inflammatory propagators through their wide production of proinflammatory cytokines in AAV, potentially providing a novel therapeutic target.
引用
收藏
页码:1432 / 1442
页数:11
相关论文
共 50 条
  • [1] Platelets release proinflammatory microparticles in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Miao, D.
    Ma, T. -T.
    Chen, M.
    Zhao, M. -H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 815 - 815
  • [2] Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Sun, Xiao-Jing
    Li, Zhi-Ying
    Chen, Min
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (01): : 11 - 21
  • [3] Microparticles as potential biomarkers of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Antovic, A.
    Mobarrez, F.
    Nordin, A.
    Gunnarsson, I.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 51 - 51
  • [4] A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
    Moura, Marta Casal
    Branco, Carolina
    Martins-Martinho, Joana
    Ferraro, Jose Luis
    Berti, Alvise
    Nogueira, Estela
    Ponte, Cristina
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [5] Influenza vaccination and anti-neutrophil cytoplasmic antibody-associated vasculitis
    Wiwanitkit, Viroj
    NEPHROLOGY, 2015, 20 (07) : 511 - 512
  • [6] Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Richard W. Lee
    David P. D’Cruz
    Drugs, 2008, 68 : 747 - 770
  • [7] Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis
    Hruskova, Zdenka
    Geetha, Duvuru
    Tesar, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i159 - i163
  • [8] Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis
    Tervaert, JWC
    Stegeman, CA
    Kallenberg, CGM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02): : 211 - 217
  • [9] AN OVERVIEW OF PHARMACOTHERAPY FOR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Stasi, R.
    DRUGS OF TODAY, 2010, 46 (12) : 919 - 928
  • [10] Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
    Binda, Valentina
    Favi, Evaldo
    Calatroni, Marta
    Moroni, Gabriella
    MEDICINA-LITHUANIA, 2021, 57 (12):